Mostafa Analoui

(Head of Healthcare and Life Sciences, Livingston Group)

“Thanks for inviting me to attend this conference, which I found it extremely valuable and worth attending. This was first time I joined for PharmaFinance and I was quite impressed with range and quality of companies presenting. Also, organizers provided ample opportunities for investors and entrepreneurs to interact and learn about unique science and technology being offered.”


Margaret Beer, PhD

(Senior Director and Head Licensing and External Research, Europe, Merck Sharp & Dohme)

“Thank you for yet another splendid event last week in Roma, and for giving me the opportunity to present on behalf of Merck. It really is appreciated especially as the event continues to grow. I much enjoyed my interactions with the other attendees – you managed to draw a very interesting and varied list of contributors offering opportunities ranging from experimental services in space to brain activity assessment during exposure advertising. What other conference offers that! I hope to see you again soon. Until then take special care”


Nizar Ali

(Managing Director – Venture Development, Accounting and Intellectual Property, FirstFloor Capital)

The trip was good as it gave me a chance to interact with industry participants and to better understand biotechnology industry in Italy.

In Malaysia, we have a one stop agency for the biotechnology industry which is called Malaysian Biotechnology Corporation Sdn Bhd (“www.biotechcorp.com.my”).

As a VC, we are constantly looking out for investments and international collaborators for our investee companies. We found a few potential collaborators in the area of diagnostic providers at the event and we hope we could secure some working relationships soon. We were also referred to several potential investment deals by other participants.


Dr. Y. Haj-Ahmad, M.Sc., Ph.D.

(President & CEO, Norgen Biotek Corp.)

“It was real pleasure meeting you. Thank you very much for your hospitality. Your assistants were extremely helpful. The meeting went very well and it was very well organized.”


Vijai Kumar, MD

(President & Chief Medical Officer, Excel Life Sciences, Inc.)

“I sincerely thank you for providing me the opportunity to witness your magic at work in Rome!! It is truly astonishing to see so many diverse persons pursue a single objective partner with Lazio industry.

It was an extremely useful learning experience for me and I hope to convert my meetings with Angelini and Menarini to successful case studies for you to present at the next year meeting!! l certainly let you know of the progress I make.

You mentioned about involving India next year. l be my privilege to provide any inputs you may need.

Once again, my sincere thanks and look forward to a continuing association.”


Marco Mochi

(Executive Business Development, Sigma-Tau SpA)

“The Zangani team is well organized, and has effective networking. Excellent quality of the services, and a good introduction to the emerging world of Biotech Companies and the Financial Community. His input on international licensing and brought great opportunities to Sigma-Tau and his clients.”


Riccardo Carbucicchio

(Head of Business Development and Licensing, Novartis Pharma)

“The Zangani Investor Community exceeded my expectations. I had an interesting meeting, entered in contact with a differentiated pool of people, and last but not least, I had fun. I found several cultural inputs helpful to pursue my business objectives, and exposing the participants to a broad spectrum of contacts extremely diversified thus offering the possibility to expand networks, fostering new opportunities.”


Mark Step

(TCL America)

“I wanted to say thank you for the opportunity to attend the Pharma Finance Conference 2009 in Rome. You and your staff should be commended for putting together a professional and impressive conference.”


Silvia Trasciatti, PhD

(Director, Research and Development Division, Abiogen Pharma S.p.A.)

“The event was extremely useful in terms of networking and building of relationships, in a relaxed and exclusive atmosphere. All attendees had similar interests but also different background: Pharmafinance offered a great environment to share experiences and create business opportunities.”


Robert Beckman

(Managing Partner, The Channel Group LLC)

“Thank you once again for the invitation to Pharma Finance 2009. I now have a great appreciation for the opportunities that may exist in Italy. I would like to have the opportunity to introduce you to my partners and to discuss how we might collaborate on opportunities. ”


Fabio Liviero

(Product Manager, HIV & Hepatitis – GSK Italy)

“Thank for inviting me to attend Pharma Finance 2009 in Rome. It was an opportunity to enlarge my point of view in pharma and better understand the mechanism of worldwide biotech players. Compliments for this original, for Italy and Lazio, initiative and to be part of a very constructive professional networking.”


Alessandro Bossi

(Director, New Business and M&A, Helsinn Healthcare S.A.)

“Pharma Finance is an excellent meeting where small Italian ventures can interact with a selected international audience. It is a great initiative that should be replicated on a larger scale. Leonardo is an energetic and proactive host. I look forward to the next conference.”

Incoming search terms:

  • 1K4W
  • VORF